NPI: 1609166925 · RACINE, WI 53405 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/08/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/08/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 33,747 | $653K |
| 2019 | 29,298 | $450K |
| 2020 | 33,026 | $387K |
| 2021 | 30,137 | $471K |
| 2022 | 20,927 | $534K |
| 2023 | 14,833 | $452K |
| 2024 | 11,113 | $418K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 71,223 | 4,903 | $3.34M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 43,354 | 2,300 | $11K |
| A4657 | Syringe, with or without needle, each | 4,235 | 3,096 | $9K |
| 90945 | 397 | 12 | $4K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,423 | 192 | $3K |
| J1756 | Injection, iron sucrose, 1 mg | 11,482 | 2,517 | $2K |
| J1270 | Injection, doxercalciferol, 1 mcg | 23,428 | 1,867 | $178.82 |
| 90674 | 151 | 124 | $114.65 | |
| 83970 | 2,562 | 2,163 | $21.74 | |
| 82728 | 2,159 | 1,789 | $5.51 | |
| 83550 | 2,218 | 1,854 | $3.54 | |
| 86706 | 32 | 26 | $2.78 | |
| 83540 | 2,378 | 1,957 | $2.63 | |
| 85041 | 3,095 | 2,534 | $1.58 | |
| 85048 | 3,090 | 2,529 | $1.34 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 998 | 473 | $0.00 |
| 90662 | 16 | 14 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 194 | 159 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 612 | 473 | $0.00 |
| 0011A | 13 | 13 | $0.00 | |
| 87340 | 21 | 19 | $0.00 |